Lakefront Biotherapeutics NV
LKFT
$27.05
-$0.44-1.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 16.63M | 910.49M | -120.02M | -120.02M | -161.43M |
| Total Depreciation and Amortization | -- | 42.85M | 41.44M | 41.44M | -- |
| Total Amortization of Deferred Charges | -- | 4.41M | -- | -- | -- |
| Total Other Non-Cash Items | -120.69M | -12.71M | 22.08M | 22.08M | 65.81M |
| Change in Net Operating Assets | 9.10M | -1.00B | -66.96M | -66.96M | 55.00M |
| Cash from Operations | -94.96M | -55.25M | -123.46M | -123.46M | -40.63M |
| Capital Expenditure | -141.20K | -1.87M | -4.72M | -4.72M | -5.36M |
| Sale of Property, Plant, and Equipment | 1.51M | 449.30K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 2.69M | 1.89M | -25.19M | -25.19M | 33.60M |
| Other Investing Activities | 66.51M | 84.07M | 114.69M | 114.69M | 60.95M |
| Cash from Investing | 70.57M | 84.54M | 84.79M | 84.79M | 89.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -510.00K | -405.00K | -600.00K | -600.00K | -1.01M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -585.30K | -471.50K | -681.00K | -681.00K | -1.06M |
| Foreign Exchange rate Adjustments | 803.30K | -1.57M | -1.96M | -1.96M | -1.37M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.17M | 27.25M | -41.31M | -41.31M | 46.12M |